Using its gift of excellence in science and technology, Israel is now planning to build its very own vaccine manufacturing unit, so as to become independent in supplying vaccines to its own citizens without having to rely on foreign vaccine makers.
On Monday, Israel’s Finance Ministry issued an Approach To Market request, or AtM, calling for proposals on how to construct its own internal vaccine manufacturing plant.
The Ministry said, “Up until now, Israel has been entirely dependent on importing vaccines made in other countries. The ability to develop, manufacture and license vaccines in Israel is of the utmost importance in order to confront familiar pathogens and/or unfamiliar pathogens that might severely harm the Israeli public health and economy.”
As it stands, the AtM is a precursor to a call for tenders, hence it is an information-gathering tool and not a request for proposals. The country will receive the responses from the request of the Atm following which they are expected to make a decision regarding future actions taken by the country to safeguard its citizens against any future pandemic, as much as possible.
The idea to manufacture vaccines in-house was first proposed by former Prime Minister Binyamin Netanyahu and is now being taken forward by PM Naftali Bennett, who has asked the Health Ministry to distribute the AtM.